These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27523746)

  • 1. NKT cell activation by Leishmania mexicana LPG: Description of a novel pathway.
    Zamora-Chimal J; Fernández-Figueroa EA; Ruiz-Remigio A; Wilkins-Rodríguez AA; Delgado-Domínguez J; Salaiza-Suazo N; Gutiérrez-Kobeh L; Becker I
    Immunobiology; 2017 Feb; 222(2):454-462. PubMed ID: 27523746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKT cells in leishmaniasis.
    Zamora-Chimal J; Hernández-Ruiz J; Becker I
    Immunobiology; 2017 Apr; 222(4):641-646. PubMed ID: 28012583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host.
    Villaseñor-Cardoso MI; Salaiza N; Delgado J; Gutiérrez-Kobeh L; Pérez-Torres A; Becker I
    Parasite Immunol; 2008 Aug; 30(8):425-34. PubMed ID: 18507782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
    Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical role for lipophosphoglycan in proinflammatory responses of dendritic cells to Leishmania mexicana.
    Aebischer T; Bennett CL; Pelizzola M; Vizzardelli C; Pavelka N; Urbano M; Capozzoli M; Luchini A; Ilg T; Granucci F; Blackburn CC; Ricciardi-Castagnoli P
    Eur J Immunol; 2005 Feb; 35(2):476-86. PubMed ID: 15657947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania mexicana lipophosphoglycan activates ERK and p38 MAP kinase and induces production of proinflammatory cytokines in human macrophages through TLR2 and TLR4.
    Rojas-Bernabé A; Garcia-Hernández O; Maldonado-Bernal C; Delegado-Dominguez J; Ortega E; Gutiérrez-Kobeh L; Becker I; Aguirre-Garcia M
    Parasitology; 2014 May; 141(6):788-800. PubMed ID: 24512642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
    Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against
    Osero BO; Cele Z; Aruleba RT; Maine RA; Ozturk M; Lutz MB; Brombacher F; Hurdayal R
    Front Immunol; 2021; 12():759021. PubMed ID: 35154068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines.
    Cañeda-Guzmán IC; Salaiza-Suazo N; Fernández-Figueroa EA; Carrada-Figueroa G; Aguirre-García M; Becker I
    PLoS One; 2014; 9(11):e112410. PubMed ID: 25397678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan.
    Pinheiro RO; Pinto EF; de Matos Guedes HL; Filho OA; de Mattos KA; Saraiva EM; de Mendonça SC; Rossi-Bergmann B
    Vaccine; 2007 Mar; 25(14):2716-22. PubMed ID: 16814903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania mexicana Lipophosphoglycan Activates Dermal γδ T Cells with Participation of TLR2.
    Soto-Olguín N; Zamora-Chimal J; Delgado-Domínguez J; Becker I
    Acta Parasitol; 2023 Mar; 68(1):122-129. PubMed ID: 36434381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.
    Pinto EF; de Mello Cortezia M; Rossi-Bergmann B
    Vaccine; 2003 Sep; 21(25-26):3534-41. PubMed ID: 12922080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses.
    Srivastava S; Pandey SP; Jha MK; Chandel HS; Saha B
    Clin Exp Immunol; 2013 Jun; 172(3):403-9. PubMed ID: 23600828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis.
    Stamm LM; Räisänen-Sokolowski A; Okano M; Russell ME; David JR; Satoskar AR
    J Immunol; 1998 Dec; 161(11):6180-8. PubMed ID: 9834104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cutaneous leishmaniasis: interferon-dependent expression of double-stranded RNA-dependent protein kinase (PKR) via TLR2.
    Vivarini Ade C; Pereira Rde M; Teixeira KL; Calegari-Silva TC; Bellio M; Laurenti MD; Corbett CE; Gomes CM; Soares RP; Silva AM; Silveira FT; Lopes UG
    FASEB J; 2011 Dec; 25(12):4162-73. PubMed ID: 21846836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental infection of Balb/c mice with Leishmania panamensis and Leishmania mexicana: induction of early IFN-gamma but not IL-4 is associated with the development of cutaneous lesions.
    Guevara-Mendoza O; Une C; Franceschi Carreira P; Orn A
    Scand J Immunol; 1997 Jul; 46(1):35-40. PubMed ID: 9246206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with Leishmania mexicana LPG induces PD-1 in CD8⁺ and PD-L2 in macrophages thereby suppressing the immune response: a model to assess vaccine efficacy.
    Martínez Salazar MB; Delgado Domínguez J; Silva Estrada J; González Bonilla C; Becker I
    Vaccine; 2014 Mar; 32(11):1259-65. PubMed ID: 24462405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63).
    Mendonça SC; Russell DG; Coutinho SG
    Clin Exp Immunol; 1991 Mar; 83(3):472-8. PubMed ID: 2004486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages.
    Ibraim IC; de Assis RR; Pessoa NL; Campos MA; Melo MN; Turco SJ; Soares RP
    Parasit Vectors; 2013 Mar; 6():54. PubMed ID: 23497381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.